Kobayashi, Taku
Siegmund, Britta
Le Berre, Catherine
Wei, Shu Chen
Ferrante, Marc
Shen, Bo
Bernstein, Charles N.
Danese, Silvio
Peyrin-Biroulet, Laurent
Hibi, Toshifumi
Article History
Accepted: 21 July 2020
First Online: 10 September 2020
Competing interests
: T.K. receives research support from AbbVie GK, Alfresa Pharma, EA Pharma, Kyorin Pharmaceutical Co., Ltd, Mochida Pharmaceutical, Nippon Kayaku, Otsuka Holdings, Thermo Fisher Scientific and ZERIA; receives advisory fees from AbbVie GK, Activaid, Alfresa Pharma, Bristol-Myers Squibb, Celltrion, CovidienÐ, Eli Lilly, Ferring Pharmaceuticals, Gilead Sciences, Janssen, Kissei, Kyorin Pharmaceutical, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda Pharmaceutical and Thermo Scientific and receives lecture fees from AbbVie GK, Astellas, Alfresa Pharma, Celltrion, EA Pharma, Gilead Sciences, Janssen, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Takeda Pharmaceutical and ZERIA. B. Siegmund received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, and Takeda (B. Siegmund served as representative of the Charité) and has served as consultant for AbbVie, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus and Takeda. C.L.B. receives honoraria from AbbVie and Ferring. S.C.W. reports consultancy fees from AbbVie, AbGenomics, Celltrion, Ferring Pharmaceuticals Inc., Gilead, Janssen, Pfizer, Takeda, and Tanabe and receives lecture fees from AbbVie, Celltrion, Eisai, Excelsior Biopharma Inc., Ferring Pharmaceuticals Inc., Janssen, Takeda, Tanabe, Tillotts Pharma, and TSPC (Taiwan Specialty Pharma Corp.). M.F. receives research grants from Amgen, Biogen, Janssen, Pfizer, and Takeda and receives consultancy fees from AbbVie, Boehringer-Ingelheim, Janssen, MSD, Pfizer, Sandoz, and Takeda and receives speaker fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, and Takeda. B. Shen receives consultant fees for AbbVie, Takeda and Janssen. C.N.B. has received educational grants from AbbVie Canada, Janssen Canada, Pfizer Canada, Shire Canada, and Takeda Canada and a research grant from AbbVie Canada. C.N.B. has performed contract research for AbbVie, Boehringer Ingelheim, Celgene, Janssen, Pfizer and Roche. He is on the advisory boards for AbbVie Canada, Janssen Canada, Pfizer Canada, Takeda Canada, and Shire Canada and consulted to Mylan Pharmaceuticals. S.D. receives consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ely Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc., and Vifor. L.P.-B. receives research grants from AbbVie, MSD, and Takeda and reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehringer Ingelheim, BMS, Celltrion, Celgene, Enterome, Enthera, Ferring, Fresenius, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Lilly, MSD, Mylan, Nestle, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Vifor, and Tillots and stock options from CTMA. T.H. has received research grants from AbbVie, EA Pharma, JIMRO, Otuska Holdings, and Zeria Pharmaceuticals and lecture fees from Aspen Japan KK, AbbVie GK, Ferring, Gilead Sciences, Janssen, JIMRO, Kissei Pharmaceutical, Mitsubishi-Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku Pfizer, Takeda Pharmaceutical, and Zeria Pharmaceutical and advisory or consultancy fees from AbbVie, Bristol-Myers Squibb, Celltrion, EA Pharma, Eli Lilly, Gilead Sciences, Janssen, Kyorin, Mitsubishi-Tanabe Pharma, Nichi-Iko Pharmaceutical, Pfizer, Takeda Pharmaceutical, and Zeria Pharmaceuticals.